Childhood Immunization Schedule 2016

<jats:p>None</jats:p>

A school based immunization program to provide catch-up doses for school children and adolescents has been established .Measles-Rubella (MR) and Tetanus-Diphtheria (Td) vaccines are administered to Grade 1 and Grade 7 students enrolled in public schools Human Papillomavirus (HPV) shall be given to female children 9-10 years old at health facilities in priority provinces.Quadrivalent HPV 2 doses are given at 0, 6 months.

Japanese Encephalitis Vaccine (JE)
Given subcutaneously Given at a minimum age of 9 months Children 9 months to 17 years of age should receive one primary dose followed by a booster dose 12-24 months after the primary dose Individuals 18 years and older should receive a single dose only

Japanese Encephalitis
Summary: Epidemiology of JE in the Philippines

Hemophilus influenzae Type b Conjugate Vaccine (Hib)
Children who are hematopoetic stem cell transplant recipients should be reimmunized with 3 doses of Hib vaccine, 6-12 months after transplant regardless of vaccination history: doses should be given 8 weeks apart Unimmunized children aged 15 months and older undergoing elective splenectomy, give one of Hib containing vaccine at least 14 days before procedure Give one dose of Hib vaccine to unimmunized children 5-18 years old who have anatomic/functional asplenia (including sickle cell disease) and HIV infection

Interim Recommendation for Use: Dengue Tetravalent Vaccine Committee on Immunization Pediatric Infectious Disease Society of the Philippines
The Philippine Food and Drug Administration (FDA) released a Certificate of Product Registration (CPR) for Dengue Tetravalent Vaccine on 22 December 2015, which authorizes marketing of this product to local consumers.Since the CPR was signed after the completion of the Committee's regular meetings and after its deliberation with various stakeholder, this interim recommendation is made for the clinician's guidance.
The Dengue Tetravalent Vaccine is a live attenuated vaccine containing dengue serotypes 1 to 4. The recommended age indication is from 9 to 45 years based on studies showing optimal safety and efficacy within these age group.There is insufficient data for the safe use of this vaccine in children younger than 9 years.

Background
and 2 nd dose over 3 rd dose Vaccine Substitutions DTaP-IPV-Hep B-Hib is not available for any dose of infant/toddler primary series Alternative: DTaP-IPV/Hib co-administered with stand alone Hep B OR DTaP-IPV co-administered with Hep B and Hib stand alone vaccines DTaP-IPV/Hib is not available for any dose of infant/toddler series : Alternative: DTaP-IPV co-administered with Hib stand alone vaccine OR DTaP-IPV-Hep B-Hib vaccine DTaP-IPV is not available for any dose of infant/toddler series Alternative: DTaP co-administered with IPV and Hib stand alone vaccines

Influenza Vaccine (Trivalent/Quadrivalent)
1. JE is endemic in the Philippines:JE is responsible for 7.4% to 40% of meningitis-encephalitis syndrome JE in the Philippines affects predominantly children younger than 15 years old Given at a minimum age of 6 months The dose of influenza vaccine is 0.25 ml for children 6 months to 35 months and 0.5 ml for children 36 months to 18 years Children 6 to 8 years receiving influenza vaccine for the first time should receive 2 doses separated by at least 4 weeks.If only one dose was given during the previous influenza season, give 2 doses of the vaccine then 1 dose yearly thereafter.